Form 8-K

8-K — Change Agents Corporation.

Accession: 0001213900-26-114381

Filed: 2026-10-30

Period: 2026-10-30

CIK: 0001630212

SIC: 7371 (SERVICES-COMPUTER PROGRAMMING SERVICES)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Submission of Matters to a Vote of Security Holders

Item: Financial Statements and Exhibits

Documents

8-K — ea0309957-8k_change.htm (Primary)

EX-10.1 — AMENDMENT NO. 1 TO AVALON GLOBOCARE CORP. 2026 STOCK INCENTIVE PLAN (ea030995701ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0309957-8k_change.htm · Sequence: 1

false

0001630212

2026-10-30

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

October 30, 2026

Change Agents Corporation

(Exact name of registrant as specified in its charter)

Delaware

001-38728

47-1685128

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I. R. S. Employer

Identification No.)

4400 Route 9 South, Suite 3100

Freehold, NJ 07728

(Address of principal executive offices, including

ZIP code)

(732) 780-4400

(Registrant’s telephone number, including

area code)

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant

to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.0001 par value

CHGA

The Nasdaq Capital Market

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure

of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the Special Meeting

(as defined below) on October 30, 2026 , the shareholders of Change Agents Corporation (the “Company”) approved Amendment

No. 1 to the Avalon GloboCare Corp. Stock Incentive Plan (the “Plan Amendment’) to increase the number of shares of common

stock reserved for issuance thereunder to 500,000 shares from 100,000 shares.

The

foregoing descriptions of the Plan Amendment is not complete and are qualified in its entirety by reference to the full text of the Plan

Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 30, 2026, the Company held a special

meeting of stockholders (the “Special Meeting”) for the purpose of holding a stockholder vote on Proposals 1, 2, 3, 4, 5,

6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, and 17 set forth below. A total of 406,853 shares of the Company’s common stock, constituting

a quorum, were represented in person or by valid proxies at the Special Meeting.

At the Special Meeting, the Company’s stockholders:

1. Approved the potential issuance, for the purposes of complying with Nasdaq Listing Rule 5635(d), of the

Company’s common stock pursuant to that certain Equity Purchase Agreement, dated July 22, 2026 as amended by that certain First

Amendment thereto dated August 21, 2026 and further amended by that certain Second Amendment dated September 9, 2026, by and between Company

and Hudson Global Ventures, LLC (the “ELOC Proposal”);

2. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 46,297 shares

of the Company’s common stock issuable upon the exercise of a common stock purchase warrant issued to Hudson Global Ventures, LLC,

pursuant to that certain equity purchase agreement dated as of July 22, 2026 by and between Company and Hudson Global Ventures, LLC (the

“ELOC Warrant Shares Proposal”);

3. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), any 20% Issuance (as defined

in the Company’s Definitive Proxy Statement, filed with the Securities and Exchange Commission on September 29, 2026 (the “Proxy

Statement”)) made by the Company that is less than the Minimum Price (as defined in the Proxy Statement) and is within the Nasdaq

parameters described in the Proxy Statement (the “Future Issuances Proposal”);

4. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of the Company’s

common stock issuable upon conversion of a promissory note, dated February 11, 2026, issued to Vanquish Funding Group, Inc. (the “February

11th Note Conversion Proposal”);

5. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of the Company’s

common stock issuable upon the conversion of a promissory note, dated February 19, 2026, issued to Vanquish Funding Group, Inc. (the “February

19th Note Conversion Proposal”);

6. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 18,000 shares

of the Company’s common stock pursuant to that certain Forbearance Letter Agreement, dated July 24, 2026, by and between Company

and Agile Lending, LLC (the “Forbearance Shares Proposal”);

7. Approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended,

to increase the number of authorized shares of common stock from 100,000,000 to 125,000,000 (the “Charter Amendment Proposal”);

-1-

8. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 15,000 shares

of our common stock pursuant to that certain consulting agreement dated as of July 1, 2026, by and between the Company and a consultant

for certain advisory services (the “July 1st Consultant Shares Proposal”);

9. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 30,000 shares

of our common stock pursuant to that certain consulting agreement dated as of July 1, 2026, as amended on July 30, 2026 by and between

the Company and a consultant for certain advisory services (the “First July 30th Consultant Shares Proposal”);

10. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 37,500 shares

of our common stock pursuant to that certain consulting agreement dated as of July 30, 2026, by and between the Company and a consultant

for certain advisory services (the “Second July 30th Consultant Shares Proposal”);

11. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 10,000 shares

of our common stock pursuant to that certain consulting agreement dated as of August 1, 2026, by and between the Company and a consultant

for certain advisory services (the “August 1st Consultant Shares Proposal”);

12. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of a pre-funded

warrant to purchase 50,000 shares of our common stock under that certain Note Purchase Agreement dated August 18, 2026 by and between

the Company and the investors set forth therein (the “August 2026 Pre-Funded Warrant Proposal”);

13. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 15,000 shares

of our common stock in respect of a “most favored nations” provision granted to noteholders in June 2026 (the “MFN Shares

Proposal”);

14. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of a pre-funded

warrant to purchase 100,000 shares of our common stock under that certain Note Purchase Agreement dated September 8, 2026 by and between

the Company and the investors set forth therein (the “September 2026 Pre-Funded Warrant Proposal”);

15. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of pre-funded warrants

to purchase 84,000 shares of our common stock under those certain waivers dated each of September 10, 2026 and September 14, 2026 by and

between the Company and the investors set forth therein (the “Waiver Pre-Funded Warrant Proposal”);

16. Approved Amendment No. 1 to the Avalon GloboCare Corp. Stock Incentive Plan (the “Equity Plan Amendment

Proposal”); and

17. Approved the adjournment of the Special Meeting, if necessary or advisable, to solicit additional

proxies in favor of any of the foregoing proposals if there are not sufficient votes to approve any such proposals (the

“Adjournment Proposal”).

-2-

The final results for each of the matters submitted

to a vote of shareholders at the Special Meeting, as set forth in the Company’s Proxy Statement, are as follows:

Proposal 1. At the Special Meeting, the

stockholders approved the ELOC Proposal. The result of the votes to approve the ELOC Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,219

1,595

248,012

Proposal 2. At the Special Meeting, the

stockholders approved the ELOC Warrant Shares Proposal. The result of the votes to approve the ELOC Warrant Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

156,967

1,848

248,012

Proposal 3. At the Special Meeting, the

stockholders approved the Future Issuances Proposal. The result of the votes to approve the Future Issuances Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

155,790

3,014

248,012

Proposal 4. At the Special Meeting, the

stockholders approved the February 11th Note Conversion Proposal. The result of the votes to approve the February 11th

Note Conversion Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,210

1,273

358

248,012

Proposal 5. At the Special Meeting, the

stockholders approved the February 19th Note Conversion Proposal. The result of the votes to approve the February 19th

Note Conversion Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,219

1,270

352

248,012

Proposal 6. At the Special Meeting, the

stockholders approved the Forbearance Shares Proposal. The result of the votes to approve the Forbearance Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,794

1,020

248,012

Proposal 7. At the Special Meeting, the

stockholders approved the Charter Amendment Proposal. The result of the votes to approve the Charter Amendment Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

349,819

55,844

1,190

Proposal 8. At the Special Meeting, the

stockholders approved the July 1st Consultant Shares Proposal. The result of the votes to approve the July 1st Consultant

Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

156,950

1,865

248,012

Proposal 9. At the Special Meeting, the

stockholders approved the First July 30th Consultant Shares Proposal. The result of the votes to approve the First July 30th Consultant

Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,204

1,610

248,012

Proposal 10. At the Special Meeting, the

stockholders approved the Second July 30th Consultant Shares Proposal. The result of the votes to approve the Second July 30th

Consultant Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

156,948

1,861

248,012

-3-

Proposal 11. At the Special Meeting, the

stockholders approved the August 1st Consultant Shares Proposal. The result of the votes to approve the August 1st Consultant Shares Proposal

was as follows:

For

Against

Abstain

Broker Non-Votes

156,958

1,851

248,012

Proposal 12. At the Special Meeting, the

stockholders approved the August 2026 Pre-Funded Warrant Proposal. The result of the votes to approve the August 2026 Pre-Funded Warrant

Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,302

1,207

332

248,012

Proposal 13. At the Special Meeting, the

stockholders approved the MFN Shares Proposal. The result of the votes to approve the MFN Shares Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,294

1,535

248,012

Proposal 14. At the Special Meeting, the

stockholders approved the September 2026 Pre-Funded Warrant Proposal. The result of the votes to approve the September 2026 Pre-Funded

Warrant Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

157,055

1,454

332

248,012

Proposal 15. At the Special Meeting, the

stockholders approved the Waiver Pre-Funded Warrant Proposal. The result of the votes to approve the Waiver Pre-Funded Warrant Proposal

was as follows:

For

Against

Abstain

Broker Non-Votes

157,026

1,483

332

248,012

Proposal 16. At the Special Meeting, the

stockholders approved the Equity Plan Amendment Proposal. The result of the votes to approve the Equity Plan Amendment Proposal was as

follows:

For

Against

Abstain

Broker Non-Votes

146,588

10,434

1,819

248,012

Proposal 17. At the Special Meeting, the

stockholders approved the Adjournment Proposal. The result of the votes to approve the Adjournment Proposal was as follows:

For

Against

Abstain

Broker Non-Votes

346,627

51,443

8,783

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibit listed in the following Exhibit Index

is filed as part of this Current Report on Form 8-K.

Exhibit No.

Description of Exhibit

10.1

Amendment No. 1 to Avalon GloboCare Corp. 2026 Stock Incentive Plan

-4-

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Date: October 30, 2026

Change Agents Corporation

/s/ Sam Knipper

Sam Knipper

Chief Financial Officer

-5-

EX-10.1 — AMENDMENT NO. 1 TO AVALON GLOBOCARE CORP. 2026 STOCK INCENTIVE PLAN

EX-10.1

Filename: ea030995701ex10-1.htm · Sequence: 2

Exhibit 10.1

AMENDMENT NO. 1 TO THE

AVALON GLOBOCARE CORP.

2026 STOCK INCENTIVE PLAN

Dated: October 30, 2026

This Agreement amends the Avalon

GloboCare Corp. 2026 Stock Incentive Plan (the “Plan”). All capitalized terms not defined herein shall have the meanings

set forth in the Plan.

R E C I T A L S

WHEREAS, Section 17.2

of the Plan reserves to the Board of Directors (“Board”) of Change Agents Corporation f/k/a Avalon GloboCare Corp.

(the “Company”) the right to amend the Plan from time to time;

WHEREAS, on August 28, 2026,

the Company effected a 1-for-20 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Stock

Split”), whereby every twenty (20) shares of common stock issued and outstanding immediately prior to the Reverse Stock Split

were automatically combined and reclassified into one (1) share of common stock, and the number of shares under the Plan was proportionally

adjusted in accordance with Section 4.3 of the Plan to reflect the Reverse Stock Split; and

WHEREAS, following the Reverse

Stock Split, the Board desires to amend the Plan to increase the number of shares available for awards under the Plan to five hundred

thousand (500,000) shares (on a post-Reverse Stock Split basis), which represents an increase over the number of shares available under

the Plan after giving effect to the Reverse Stock Split, subject to approval by the Company’s stockholders.

NOW, THEREFORE, the Plan is

hereby amended as follows:

1. Amendment to Plan Share

Limitation.

Section 4.1(a) of

the Plan is amended and restated in its entirety as follows:

“(a) Subject

to adjustment pursuant to Sections 4.1(b) and 4.3 and any other applicable provisions hereof, the maximum aggregate number of shares

of Common Stock which may be issued under all Awards granted to Participants under the Plan shall be five hundred thousand (500,000) shares.”

2. No Other Changes.

Except as set forth herein, the Plan shall remain in full force and effect without modification.

IN WITNESS WHEREOF, the undersigned,

a duly authorized officer of the Company, has executed this Amendment as of the date first above written as evidence of its adoption by

the Company.

CHANGE AGENTS CORPORATION

By:

/s/ Sam Knippler

Name:

Sam Knipper

Title:

Chief Financial Officer

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.3

Cover

Oct. 30, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Oct. 30, 2026

Entity File Number

001-38728

Entity Registrant Name

Change Agents Corporation

Entity Central Index Key

0001630212

Entity Tax Identification Number

47-1685128

Entity Incorporation, State or Country Code

Entity Address, Address Line One

4400 Route 9 South

Entity Address, Address Line Two

Suite 3100

Entity Address, City or Town

Freehold

Entity Address, State or Province

Entity Address, Postal Zip Code

07728

City Area Code

732

Local Phone Number

780-4400

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common stock, $0.0001 par value

Trading Symbol

CHGA

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration